Net Cash Provided by (Used in) Financing Activities of ALTEROLA BIOTECH INC. from 30 Sep 2010 to 30 Jun 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
ALTEROLA BIOTECH INC. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 30 Sep 2010 to 30 Jun 2024.
  • ALTEROLA BIOTECH INC. Net Cash Provided by (Used in) Financing Activities for the quarter ending 30 Jun 2024 was $923,003.
  • ALTEROLA BIOTECH INC. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $1,468,856, a 22% increase from 2022.
  • ALTEROLA BIOTECH INC. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $1,199,073.
  • ALTEROLA BIOTECH INC. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $9,669, a 119% decline from 2020.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

ALTEROLA BIOTECH INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $923,003 +$961,538 01 Apr 2024 30 Jun 2024 10-Q/A 25 Nov 2024 2025 Q1
Q2 2023 $38,535 -$89,915 -175% 01 Apr 2023 30 Jun 2023 10-Q/A 25 Nov 2024 2025 Q1
Q2 2022 $51,380 +$50,634 +6787% 01 Apr 2022 30 Jun 2022 10-Q 15 Aug 2023 2024 Q1
Q2 2021 $746 01 Apr 2021 30 Jun 2021 10-Q 18 Aug 2022 2023 Q1
Q4 2020 $0 $0 01 Oct 2020 31 Dec 2020 10-Q 28 May 2021 2021 Q1
Q4 2019 $0 $0 01 Oct 2019 31 Dec 2019 10-Q 28 May 2021 2021 Q1
Q4 2018 $0 $0 01 Oct 2018 31 Dec 2018 10-Q 02 Apr 2021 2020 Q1
Q4 2017 $0 $0 01 Oct 2017 31 Dec 2017 10-Q 29 Dec 2020 2019 Q1
Q4 2016 $0 -$25,000 -100% 01 Oct 2016 31 Dec 2016 10-Q 30 Aug 2018 2017 Q1
Q4 2015 $25,000 +$5,000 +25% 01 Oct 2015 31 Dec 2015 10-Q 30 Aug 2018 2017 Q1
Q4 2014 $20,000 +$20,000 01 Oct 2014 31 Dec 2014 10-Q 05 Feb 2016 2016 Q1
Q4 2013 $0 $0 01 Oct 2013 31 Dec 2013 10-Q 23 Feb 2015 2015 Q1
Q4 2012 $0 $0 01 Oct 2012 31 Dec 2012 10-Q 14 May 2014 2014 Q1
Q4 2011 $0 -$50,000 -100% 01 Oct 2011 31 Dec 2011 10-Q 17 Mar 2014 2013 Q1
Q4 2010 $50,000 01 Oct 2010 31 Dec 2010 10-Q 05 Mar 2014 2012 Q1

ALTEROLA BIOTECH INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $1,468,856 +$269,783 +22% 01 Apr 2023 31 Mar 2024 10-K 18 Jul 2024 2024 FY
2022 $1,199,073 +$1,208,742 01 Apr 2022 31 Mar 2023 10-K 18 Jul 2024 2024 FY
2021 $9,669 -$59,669 -119% 01 Apr 2021 31 Mar 2022 10-K 10 Jul 2023 2023 FY
2020 $50,000 +$50,000 01 Apr 2020 31 Mar 2021 10-K/A 14 Sep 2022 2022 FY
2019 $0 $0 01 Oct 2018 30 Sep 2019 10-KT 09 Jun 2021 2021 FY
2018 $0 $0 01 Oct 2017 30 Sep 2018 10-K 26 Mar 2021 2019 FY
2017 $0 -$25,000 -100% 01 Oct 2016 30 Sep 2017 10-K 14 Dec 2020 2018 FY
2016 $25,000 +$5,000 +25% 01 Oct 2015 30 Sep 2016 10-K 17 Dec 2018 2017 FY
2015 $20,000 +$13,250 +196% 01 Oct 2014 30 Sep 2015 10-K 30 Aug 2018 2016 FY
2014 $6,750 -$33,250 -83% 01 Oct 2013 30 Sep 2014 10-K 30 Dec 2015 2015 FY
2013 $40,000 +$40,000 01 Oct 2012 30 Sep 2013 10-K 13 Jan 2015 2014 FY
2012 $0 -$61,958 -100% 01 Oct 2011 30 Sep 2012 10-K 13 May 2014 2013 FY
2011 $61,958 -$68,042 -52% 01 Oct 2010 30 Sep 2011 10-K 11 Mar 2014 2012 FY
2010 $130,000 01 Oct 2009 30 Sep 2010 10-K 27 Feb 2014 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.